Sustained low efficiency dialysis in the continuous mode (C-SLED): Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients

Abdulla K. Salahudeen, Vikas Kumar, Niti Madan, Lianchun Xiao, Amit Lahoti, Joshua Samuels, Joseph Nates, Kristen Price

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background and objectives: Oliguric, hypotensive patients who require large amounts of fluids may benefit from sustained low-efficiency dialysis performed continuously (C-SLED). C-SLED through higher clearance may improve survival, or through greater nutritional loss may worsen survival. No studies have assessed survival on C-SLED. The objective was to examine patient outcomes and survival predictors on C-SLED. Design, setting, participants, & measurements: The data of 199 consecutive cancer patients treated with C-SLED were analyzed. The median duration of C-SLED was 50 h. With 48 h of C-SLED, the blood urea nitrogen (BUN) and serum creatinine levels had decreased by 80% and 73%, respectively. The mean arterial pressure (MAP) was maintained despite higher ultrafiltration and reduced vasopressor use. The 30-d mortality rate was 65%. Despite excellent dialysis, the sequential organ failure assessment (SOFA) score remained predictive of mortality. In the univariate model, higher SOFA scores and lower values for MAP, blood pH, and serum albumin and creatinine levels were associated with higher mortality. Administration of total parenteral nutrition (TPN) was, however, associated with lower mortality. Results: In the multivariate model, the higher SOFA score and lower blood pH, MAP and C-SLED duration were associated with higher mortality. In a subset analysis of 129 patients who received C-SLED for at least 48 h, those with higher BUN levels, which were associated with higher TPN infusion, had a lower mortality risk. Conclusion: This first detailed report on C-SLED indicates that C-SLED can be effective and suggests a link between nutrition and survival.

Original languageEnglish (US)
Pages (from-to)1338-1346
Number of pages9
JournalClinical Journal of the American Society of Nephrology
Volume4
Issue number8
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Critical Illness
Dialysis
Organ Dysfunction Scores
Survival
Mortality
Neoplasms
Arterial Pressure
Total Parenteral Nutrition
Blood Urea Nitrogen
Creatinine
Parenteral Infusions
Ultrafiltration
Serum
Serum Albumin

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Sustained low efficiency dialysis in the continuous mode (C-SLED) : Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. / Salahudeen, Abdulla K.; Kumar, Vikas; Madan, Niti; Xiao, Lianchun; Lahoti, Amit; Samuels, Joshua; Nates, Joseph; Price, Kristen.

In: Clinical Journal of the American Society of Nephrology, Vol. 4, No. 8, 2009, p. 1338-1346.

Research output: Contribution to journalArticle

Salahudeen, Abdulla K. ; Kumar, Vikas ; Madan, Niti ; Xiao, Lianchun ; Lahoti, Amit ; Samuels, Joshua ; Nates, Joseph ; Price, Kristen. / Sustained low efficiency dialysis in the continuous mode (C-SLED) : Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. In: Clinical Journal of the American Society of Nephrology. 2009 ; Vol. 4, No. 8. pp. 1338-1346.
@article{92a569ae6b874010b2b73c5e138ef7ab,
title = "Sustained low efficiency dialysis in the continuous mode (C-SLED): Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients",
abstract = "Background and objectives: Oliguric, hypotensive patients who require large amounts of fluids may benefit from sustained low-efficiency dialysis performed continuously (C-SLED). C-SLED through higher clearance may improve survival, or through greater nutritional loss may worsen survival. No studies have assessed survival on C-SLED. The objective was to examine patient outcomes and survival predictors on C-SLED. Design, setting, participants, & measurements: The data of 199 consecutive cancer patients treated with C-SLED were analyzed. The median duration of C-SLED was 50 h. With 48 h of C-SLED, the blood urea nitrogen (BUN) and serum creatinine levels had decreased by 80{\%} and 73{\%}, respectively. The mean arterial pressure (MAP) was maintained despite higher ultrafiltration and reduced vasopressor use. The 30-d mortality rate was 65{\%}. Despite excellent dialysis, the sequential organ failure assessment (SOFA) score remained predictive of mortality. In the univariate model, higher SOFA scores and lower values for MAP, blood pH, and serum albumin and creatinine levels were associated with higher mortality. Administration of total parenteral nutrition (TPN) was, however, associated with lower mortality. Results: In the multivariate model, the higher SOFA score and lower blood pH, MAP and C-SLED duration were associated with higher mortality. In a subset analysis of 129 patients who received C-SLED for at least 48 h, those with higher BUN levels, which were associated with higher TPN infusion, had a lower mortality risk. Conclusion: This first detailed report on C-SLED indicates that C-SLED can be effective and suggests a link between nutrition and survival.",
author = "Salahudeen, {Abdulla K.} and Vikas Kumar and Niti Madan and Lianchun Xiao and Amit Lahoti and Joshua Samuels and Joseph Nates and Kristen Price",
year = "2009",
doi = "10.2215/CJN.02130309",
language = "English (US)",
volume = "4",
pages = "1338--1346",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "8",

}

TY - JOUR

T1 - Sustained low efficiency dialysis in the continuous mode (C-SLED)

T2 - Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients

AU - Salahudeen, Abdulla K.

AU - Kumar, Vikas

AU - Madan, Niti

AU - Xiao, Lianchun

AU - Lahoti, Amit

AU - Samuels, Joshua

AU - Nates, Joseph

AU - Price, Kristen

PY - 2009

Y1 - 2009

N2 - Background and objectives: Oliguric, hypotensive patients who require large amounts of fluids may benefit from sustained low-efficiency dialysis performed continuously (C-SLED). C-SLED through higher clearance may improve survival, or through greater nutritional loss may worsen survival. No studies have assessed survival on C-SLED. The objective was to examine patient outcomes and survival predictors on C-SLED. Design, setting, participants, & measurements: The data of 199 consecutive cancer patients treated with C-SLED were analyzed. The median duration of C-SLED was 50 h. With 48 h of C-SLED, the blood urea nitrogen (BUN) and serum creatinine levels had decreased by 80% and 73%, respectively. The mean arterial pressure (MAP) was maintained despite higher ultrafiltration and reduced vasopressor use. The 30-d mortality rate was 65%. Despite excellent dialysis, the sequential organ failure assessment (SOFA) score remained predictive of mortality. In the univariate model, higher SOFA scores and lower values for MAP, blood pH, and serum albumin and creatinine levels were associated with higher mortality. Administration of total parenteral nutrition (TPN) was, however, associated with lower mortality. Results: In the multivariate model, the higher SOFA score and lower blood pH, MAP and C-SLED duration were associated with higher mortality. In a subset analysis of 129 patients who received C-SLED for at least 48 h, those with higher BUN levels, which were associated with higher TPN infusion, had a lower mortality risk. Conclusion: This first detailed report on C-SLED indicates that C-SLED can be effective and suggests a link between nutrition and survival.

AB - Background and objectives: Oliguric, hypotensive patients who require large amounts of fluids may benefit from sustained low-efficiency dialysis performed continuously (C-SLED). C-SLED through higher clearance may improve survival, or through greater nutritional loss may worsen survival. No studies have assessed survival on C-SLED. The objective was to examine patient outcomes and survival predictors on C-SLED. Design, setting, participants, & measurements: The data of 199 consecutive cancer patients treated with C-SLED were analyzed. The median duration of C-SLED was 50 h. With 48 h of C-SLED, the blood urea nitrogen (BUN) and serum creatinine levels had decreased by 80% and 73%, respectively. The mean arterial pressure (MAP) was maintained despite higher ultrafiltration and reduced vasopressor use. The 30-d mortality rate was 65%. Despite excellent dialysis, the sequential organ failure assessment (SOFA) score remained predictive of mortality. In the univariate model, higher SOFA scores and lower values for MAP, blood pH, and serum albumin and creatinine levels were associated with higher mortality. Administration of total parenteral nutrition (TPN) was, however, associated with lower mortality. Results: In the multivariate model, the higher SOFA score and lower blood pH, MAP and C-SLED duration were associated with higher mortality. In a subset analysis of 129 patients who received C-SLED for at least 48 h, those with higher BUN levels, which were associated with higher TPN infusion, had a lower mortality risk. Conclusion: This first detailed report on C-SLED indicates that C-SLED can be effective and suggests a link between nutrition and survival.

UR - http://www.scopus.com/inward/record.url?scp=70349900573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349900573&partnerID=8YFLogxK

U2 - 10.2215/CJN.02130309

DO - 10.2215/CJN.02130309

M3 - Article

C2 - 19628685

AN - SCOPUS:70349900573

VL - 4

SP - 1338

EP - 1346

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 8

ER -